| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/06/1999 | EP0912754A1 Process for the fermentative production of deacylated cephalosporins |
| 05/06/1999 | EP0912753A1 Identification and comparison of protein-protein interactions and inhibitors thereof |
| 05/06/1999 | EP0912752A1 Method for polynucleotide sequencing |
| 05/06/1999 | EP0912750A1 Method for increasing sucrose content of plants |
| 05/06/1999 | EP0912749A1 Suppression of specific classes of soybean seed protein genes |
| 05/06/1999 | EP0912748A1 Modification of cryptic splice sites in heterologous genes expressed in fungi |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912746A2 MAMMALIAN TNF-$g(a) CONVERTASES |
| 05/06/1999 | EP0912745A1 Mammalian cdp-diacylglycerol synthase |
| 05/06/1999 | EP0912744A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 05/06/1999 | EP0912743A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 05/06/1999 | EP0912742A1 Viral interleukin-6 |
| 05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912739A2 Canine ob protein compositions and methods |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912737A1 Human osteoclast-specific and -related dna sequences |
| 05/06/1999 | EP0912736A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
| 05/06/1999 | EP0912735A2 Secreted proteins and polynucleotides encoding them |
| 05/06/1999 | EP0912734A1 Chimeric heteromultimer adhesins |
| 05/06/1999 | EP0912733A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
| 05/06/1999 | EP0912732A1 Gamma ii adaptin |
| 05/06/1999 | EP0912731A2 Secreted proteins |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 05/06/1999 | EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces |
| 05/06/1999 | EP0912725A1 Glycosidase enzymes |
| 05/06/1999 | EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/06/1999 | EP0912723A1 Highly productive packaging lines |
| 05/06/1999 | EP0912722A1 Method of constructing vectors for homologous recombination directed mutagenesis |
| 05/06/1999 | EP0912721A1 Vaccine preparations |
| 05/06/1999 | EP0912611A1 Human monoclonal antibodies to the hepatitis b surface antigen |
| 05/06/1999 | EP0912609A2 Fragments of leptin (ob protein) |
| 05/06/1999 | EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines |
| 05/06/1999 | EP0912607A2 Vaccines comprising synthetic genes |
| 05/06/1999 | EP0912597A1 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| 05/06/1999 | EP0912596A1 Plant plastid division genes |
| 05/06/1999 | EP0912595A1 Hodgkin's disease associated molecules and uses thereof |
| 05/06/1999 | EP0912594A1 Identification of essential survival genes |
| 05/06/1999 | EP0912593A2 Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses |
| 05/06/1999 | EP0912470A1 Method and device for purifying and enriching molecules |
| 05/06/1999 | EP0912239A1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 05/06/1999 | EP0912194A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 05/06/1999 | EP0912193A1 Vaccine to prevent streptococcal endocarditis |
| 05/06/1999 | EP0912096A2 Plant protection method |
| 05/06/1999 | EP0787299A4 Receptor for a bacillus thuringiensis toxin |
| 05/06/1999 | EP0746333B1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 05/06/1999 | EP0674650A4 Nucleic acid probes for lactobacillus detection. |
| 05/06/1999 | EP0667911B1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/06/1999 | EP0624199B1 Methods for producing thrombin |
| 05/06/1999 | EP0576439B1 Monoclonal antibody against lps core |
| 05/06/1999 | EP0541692B1 Herpes simplex virus vp16 vaccines |
| 05/06/1999 | DE19748734A1 Preparing active growth factor dimers from inclusion bodies in high yield |
| 05/06/1999 | CA2712809A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 05/06/1999 | CA2348675A1 Methods for preparing polynucleotide transfection complexes |
| 05/06/1999 | CA2316179A1 Evaluation of changes in breast cells using nipple aspirate fluid |
| 05/06/1999 | CA2308463A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | CA2308115A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | CA2307953A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | CA2307826A1 Enhancement of morphogen activity |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | CA2307171A1 A novel mitogenic cyclin and uses thereof |
| 05/06/1999 | CA2307098A1 Expression system |
| 05/06/1999 | CA2307016A1 Recombinational cloning using nucleic acids having recombination sites |
| 05/06/1999 | CA2307014A1 Viral encoded semaphorin protein receptor dna and polypeptides |
| 05/06/1999 | CA2306979A1 Epoxide hydrolase |
| 05/06/1999 | CA2306907A1 Dna base mismatch detection using flow cytometry |
| 05/06/1999 | CA2306733A1 Compositions and methods for delivery of genetic material |
| 05/06/1999 | CA2306205A1 Reduction of chlorophyll content in oil plant seeds |
| 05/06/1999 | CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | CA2305631A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
| 05/06/1999 | CA2304984A1 Binary viral expression system in plants |
| 05/06/1999 | CA2252999A1 Novel rncs |
| 05/05/1999 | CN1216067A Improvements in or retating to gene expression |
| 05/05/1999 | CN1216066A Regulation of gene expression in eukaryotes |
| 05/05/1999 | CN1216065A Export systems for recombinant proteins |
| 05/05/1999 | CN1216064A Synthetic HIV genes |
| 05/05/1999 | CN1216063A IL-6 mutein |
| 05/05/1999 | CN1215994A Rnase L activators and antisense oligonucleotides effective to treat RSV infections |
| 05/05/1999 | CN1215755A Method of introducing predetermined alteration in target sequence of genome of cell having nucleus |
| 05/05/1999 | CN1215729A Clostridium perfringens vaccine |
| 05/04/1999 | US5900525 Animal feed compositions containing phytase derived from transgenic alfalfa and methods of use thereof |
| 05/04/1999 | US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents |
| 05/04/1999 | US5900400 Protein |
| 05/04/1999 | US5900362 Nitrosomonas comprising plasmid with luciferase-beta galactosidase transcription fusion; for monitoring viability of bacteria in sewage plants |
| 05/04/1999 | US5900360 Screening protein stabilizing agents (not congo red) by incubating cell containing conformationally defective protein, determining effective concentration to improve phenotype; treatment of cystic fibrosis, scrapie |
| 05/04/1999 | CA2248171A1 Improvements in or relating to detection of salmonella |
| 05/04/1999 | CA2166850C Vectors and use thereof for capturing target genes |
| 05/04/1999 | CA2037333C Dna encoding a major mite allergen and the use thereof |
| 05/04/1999 | CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
| 05/04/1999 | CA1340522C Fusion proteins containing neighbouring histidines for improved purification |
| 05/04/1999 | CA1340521C Hepatitis b virus antigen and a process for producing the same |
| 05/04/1999 | CA1340520C Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
| 05/03/1999 | CA2249002A1 Aroc |
| 04/30/1999 | CA2249056A1 Lacc |
| 04/30/1999 | CA2248996A1 Novel ornithine carbamoyltransferase |
| 04/30/1999 | CA2248971A1 .beta.1, 3-n-acetylglucosaminyltransferase, dna encoding it and its use |
| 04/29/1999 | WO1999020799A2 Microorganism genomics, compositions and methods related thereto |